205 related articles for article (PubMed ID: 27314854)
1. Elevated Resistin Gene Expression in African American Estrogen and Progesterone Receptor Negative Breast Cancer.
Vallega KA; Liu N; Myers JS; Yu K; Sang QX
PLoS One; 2016; 11(6):e0157741. PubMed ID: 27314854
[TBL] [Abstract][Full Text] [Related]
2. Frequency of breast cancer subtypes among African American women in the AMBER consortium.
Allott EH; Geradts J; Cohen SM; Khoury T; Zirpoli GR; Bshara W; Davis W; Omilian A; Nair P; Ondracek RP; Cheng TD; Miller CR; Hwang H; Thorne LB; O'Connor S; Bethea TN; Bell ME; Hu Z; Li Y; Kirk EL; Sun X; Ruiz-Narvaez EA; Perou CM; Palmer JR; Olshan AF; Ambrosone CB; Troester MA
Breast Cancer Res; 2018 Feb; 20(1):12. PubMed ID: 29409530
[TBL] [Abstract][Full Text] [Related]
3. Differentially expressed transcripts and dysregulated signaling pathways and networks in African American breast cancer.
Stewart PA; Luks J; Roycik MD; Sang QX; Zhang J
PLoS One; 2013; 8(12):e82460. PubMed ID: 24324792
[TBL] [Abstract][Full Text] [Related]
4. African American patients with breast cancer have worse prognosis than white patients in certain subtypes and stages.
Arciero CA; Yang J; Peng L; Ward KC; O'Regan R; Sahin AA; Li X
Breast Cancer Res Treat; 2017 Dec; 166(3):743-755. PubMed ID: 28856481
[TBL] [Abstract][Full Text] [Related]
5. MYC amplification in subtypes of breast cancers in African American women.
Naab TJ; Gautam A; Ricks-Santi L; Esnakula AK; Kanaan YM; DeWitty RL; Asgedom G; Makambi KH; Abawi M; Blancato JK
BMC Cancer; 2018 Mar; 18(1):274. PubMed ID: 29523126
[TBL] [Abstract][Full Text] [Related]
6. Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer Study.
Conway K; Edmiston SN; Tse CK; Bryant C; Kuan PF; Hair BY; Parrish EA; May R; Swift-Scanlan T
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):921-30. PubMed ID: 25809865
[TBL] [Abstract][Full Text] [Related]
7. Androgen Receptor and ALDH1 Expression Among Internationally Diverse Patient Populations.
Jiagge E; Jibril AS; Davis M; Murga-Zamalloa C; Kleer CG; Gyan K; Divine G; Hoenerhoff M; Bensenhave J; Awuah B; Oppong J; Adjei E; Salem B; Toy K; Merajver S; Wicha M; Newman L
J Glob Oncol; 2018 Oct; 4():1-8. PubMed ID: 30307804
[TBL] [Abstract][Full Text] [Related]
8. Variants of estrogen-related genes and breast cancer risk in European and African American women.
Quan L; Hong CC; Zirpoli G; Roberts MR; Khoury T; Sucheston-Campbell LE; Bovbjerg DH; Jandorf L; Pawlish K; Ciupak G; Davis W; Bandera EV; Ambrosone CB; Yao S
Endocr Relat Cancer; 2014; 21(6):853-64. PubMed ID: 25228414
[TBL] [Abstract][Full Text] [Related]
9. Molecular breast cancer subtypes in premenopausal African-American women, tumor biologic factors and clinical outcome.
Ihemelandu CU; Leffall LD; Dewitty RL; Naab TJ; Mezghebe HM; Makambi KH; Adams-Campbell L; Frederick WA
Ann Surg Oncol; 2007 Oct; 14(10):2994-3003. PubMed ID: 17647064
[TBL] [Abstract][Full Text] [Related]
10. Racial differences in outcomes of triple-negative breast cancer.
Pacheco JM; Gao F; Bumb C; Ellis MJ; Ma CX
Breast Cancer Res Treat; 2013 Feb; 138(1):281-9. PubMed ID: 23400579
[TBL] [Abstract][Full Text] [Related]
11. Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American women.
Cui Y; Deming-Halverson SL; Shrubsole MJ; Beeghly-Fadiel A; Fair AM; Sanderson M; Shu XO; Kelley MC; Zheng W
Clin Breast Cancer; 2014 Dec; 14(6):417-25. PubMed ID: 24970715
[TBL] [Abstract][Full Text] [Related]
12. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Carey LA; Perou CM; Livasy CA; Dressler LG; Cowan D; Conway K; Karaca G; Troester MA; Tse CK; Edmiston S; Deming SL; Geradts J; Cheang MC; Nielsen TO; Moorman PG; Earp HS; Millikan RC
JAMA; 2006 Jun; 295(21):2492-502. PubMed ID: 16757721
[TBL] [Abstract][Full Text] [Related]
13. Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.
Ihemelandu CU; Leffall LD; Dewitty RL; Naab TJ; Mezghebe HM; Makambi KH; Adams-Campbell L; Frederick WA
J Surg Res; 2007 Nov; 143(1):109-18. PubMed ID: 17950079
[TBL] [Abstract][Full Text] [Related]
14. Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women.
O'Meara T; Safonov A; Casadevall D; Qing T; Silber A; Killelea B; Hatzis C; Pusztai L
Breast Cancer Res Treat; 2019 May; 175(1):247-259. PubMed ID: 30725384
[TBL] [Abstract][Full Text] [Related]
15. Genomic profiling of breast cancer in African-American women using MammaPrint.
Nunes RA; Wray L; Mete M; Herbolsheimer P; Smith KL; Bijelic L; Boisvert ME; Swain SM
Breast Cancer Res Treat; 2016 Oct; 159(3):481-8. PubMed ID: 27568021
[TBL] [Abstract][Full Text] [Related]
16. Combined High Resistin and EGFR Expression Predicts a Poor Prognosis in Breast Cancer.
Zeng Y; Tang CH; Wang Y; Lu HJ; Huang BF; Wang Q; Shao JK; Jin LL; Wang CQ; Teng LS
Biomed Res Int; 2020; 2020():8835398. PubMed ID: 33313320
[TBL] [Abstract][Full Text] [Related]
17. Increased circulating resistin levels in early-onset breast cancer patients of normal body mass index correlate with lymph node negative involvement and longer disease free survival: a multi-center POSH cohort serum proteomics study.
Zeidan B; Manousopoulou A; Garay-Baquero DJ; White CH; Larkin SET; Potter KN; Roumeliotis TI; Papachristou EK; Copson E; Cutress RI; Beers SA; Eccles D; Townsend PA; Garbis SD
Breast Cancer Res; 2018 Mar; 20(1):19. PubMed ID: 29566726
[TBL] [Abstract][Full Text] [Related]
18. Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activation.
Deshmukh SK; Srivastava SK; Bhardwaj A; Singh AP; Tyagi N; Marimuthu S; Dyess DL; Dal Zotto V; Carter JE; Singh S
Oncotarget; 2015 May; 6(13):11231-41. PubMed ID: 25868978
[TBL] [Abstract][Full Text] [Related]
19. Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status.
Chen L; Li CI
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1666-72. PubMed ID: 26464428
[TBL] [Abstract][Full Text] [Related]
20. Enhanced immortalization, HUWE1 mutations and other biological drivers of breast invasive carcinoma in Black/African American patients.
Andey T; Attah MM; Akwaaba-Reynolds NA; Cheema S; Parvin-Nejad S; Acquaah-Mensah GK
Gene; 2020 Dec; 763S():100030. PubMed ID: 34493366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
